Equity Analysis

Quarterly Results

    Zydus Lifesciences Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    532321
    INE010B01027
    177.8674103
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    ZYDUSLIFE
    22.15
    96402.25
    EPS(TTM)
    Face Value()
    Div & Yield %:
    43.26
    1
    0.31
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales2512.304035.403172.60
Other Operating Income108.30124.80159.80
Other Income 326.70106.60361.10
Total Income2947.304266.803693.50
Total Expenditure 1678.401787.301771.80
PBIDT1268.902479.501921.70
Interest 95.90115.40106.20
PBDT1173.002364.101815.50
Depreciation133.70130.60130.60
Tax248.60531.60407.50
Fringe Benefit Tax0.000.000.00
Deferred Tax0.901.10-127.80
Reported Profit After Tax789.801700.801405.20
Extra-ordinary Items 0.000.00-6.52
Adjusted Profit After Extra-ordinary item789.801700.801411.72
EPS (Unit Curr.)7.8516.9013.89
EPS (Adj) (Unit Curr.)7.8516.9013.89
Calculated EPS (Unit Curr.)7.8516.9113.97
Calculated EPS (Adj) (Unit Curr.)7.8516.9113.97
Calculated EPS (Ann.) (Unit Curr.)31.4067.6355.87
Calculated EPS (Adj) (Ann.) (Unit Curr.)31.4067.6355.87
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity100.60100.60100.60
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)50.5161.4460.57
PBDTM(%)46.6958.5857.22
PATM(%)31.4442.1544.29
Dividend Per Share(Rs)0.000.000.00
Diluted EPS7.8516.9013.89